Daiichi Sankyo Co 4568.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4568.T. It has been listed since 28 September 2005. In the fiscal year to 31 March 2026, it reported revenue of ¥2.12trn and net income of ¥259.87bn. At that date it held total assets of ¥4.01trn and shareholders' equity of ¥1.66trn.

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Sunao ManabeChairman of the Board, Chairman of the Executive Board, Chief Executive Officer, Representative Director, since 2012¥385.0m
• Mr. Hiroyuki OkuzawaPresident, Executive President, Chief Operating Officer, Representative Director, since 2018¥252.0m
• Mr. Takashi MatsumotoChief Human Resource Officer, Managing Executive Officer, Head of Global HR, Director
• Mr. Takashi FukuokaSenior Managing Executive Officer, Head of Global Corporate Strategy, CStO, Director¥147.0m
• Mr. Shoji HirashimaSenior Managing Executive Officer, Manager of Japan Business Unit, Representative Director¥166.0m
• Mr. Koji OgawaChief Financial Officer, Managing Executive Officer, Head of Global Corporate Planning and Management
• Mr. Toshinori AgatsumaManaging Executive Officer, Chief Director of Research and Development, Senior Director of Research
• Mr. Hiroto KashiwaseManaging Executive Officer, Chief Director of Technology
• Mr. Nobuo MurakamiManaging Executive Officer, Director of Global Corporate Strategy
• Ms. Shizuko UenoManaging Executive Officer, Chief Director of Medical Affairs in Japan Business Unit
• Mr. Akio SakuraiExecutive Officer, Chief Director of Sales in Japan Business Unit
• Mr. Akihiro TokumotoExecutive Officer, Director of Human Resource

Overall

92

Environment

99

Social

99

Governance

77

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.